Claudio Luchini retweeted
Join #PBPS for our Companion Society Session at the 2026 ASCP & CAP-ACP Joint Annual Meeting in Montréal, Canada: “Gallbladder & Biliary Pathology: Avoiding Diagnostic Pitfalls and Recognizing What Matters.” #PathTwitter
Date: Fri, Nov 20
Time: 2:30–3:30 PM
Location: 520F
Date: Fri, Nov 20
Time: 2:30–3:30 PM
Location: 520F
0
5
6
298
Claudio Luchini retweeted
Wonderful moments from the IAP Turkish Division Annual Meeting 2026 in Istanbul, Türkiye. We are pleased to share some highlights celebrating scientific exchange, friendship, and collaborations. #PBPS #PathTwitter
0
9
17
668
Claudio Luchini retweeted
November is #PancreaticCancerAwarenessMonth! 💜
Together, let’s raise awareness, support patients and families, and advance research toward better treatments.
On Nov 19, wear purple for #WorldPancreaticCancerDay and help spread the word!
pancreatic.org/november/
Together, let’s raise awareness, support patients and families, and advance research toward better treatments.
On Nov 19, wear purple for #WorldPancreaticCancerDay and help spread the word!
pancreatic.org/november/
1
8
9
310
Claudio Luchini retweeted
📢 Registration Reminder!
Join #PBPS and #USCAP for our Interactive Microscopy Course, Unlocking Pancreatobiliary Pathology, February 3–5, 2027, in Palm Springs, CA!
🔗 Register: my.uscap.org/uscap/program/…
Join #PBPS and #USCAP for our Interactive Microscopy Course, Unlocking Pancreatobiliary Pathology, February 3–5, 2027, in Palm Springs, CA!
🔗 Register: my.uscap.org/uscap/program/…
Unlocking Pancreatobiliary Pathology: A PBPS Interactive Microscopy Course, Feb 3rd-7th 2027, Palm Springs, CA
1
6
10
579
Claudio Luchini retweeted
There is a new 🎙️ Precision Pathology Podcast out! In this episode hear our chair @DrNetto in conversation with Dr. Yuri Tolkach as they discusses his team's study analyzing 2,791 whole-slide images using an open-source AI model.
🔬: podcasts.apple.com/us/podcast/can…
🔬: podcasts.apple.com/us/podcast/can…
New Precision Pathology Podcast Episode!
Can computational single-cell profiling of routine H&E slides reveal prognostic clues in lung adenocarcinoma?
In this episode of Precision Pathology, Dr. Yuri Tolkach discusses his team's study analyzing 2,791 whole-slide images using an openesearch identified lymphocyte-rich tumor environments as favorable prognostic markers, while granulocyte-rich stromal patterns were associated with poorer outcomes.
The study also demonstrates how spatial immune-tumor interactions can provide powerful prognostic information, highlighting the potential of computational pathology to enhance risk stratification using standard pathology slides.
Read manuscript here: doi.org/10.1016/j.prpa…
Listen to the full episode: clientfiles.doctorpodcasting.com/perelman_patho…
Also available on Apple Podcasts, Spotify, YouTube, RadioMD, and other major podcast platforms.
@y_tolkach
@ChemUniCologne
@Sciencedirect
#ScienceDirect
@TheUSCAP
@ESP_Pathology
@AACR
@IARCWHO
@PennPathLabMed
#PrecisionPathology
#LungAdenocarcinoma
#ComputationalPathology
#DigitalPathology
#TumorMicroenvironment
#AI
#WSI
#NSCLC
#cellularneighberhoods
0
1
4
297
Claudio Luchini retweeted
What an #EMSO26 it has been...impossible to oversee everything that has happened.
Luckily, you'll find everything you need to know in the @OncoAlert 🚨newsletter 👇
Luckily, you'll find everything you need to know in the @OncoAlert 🚨newsletter 👇
Dear colleagues,
We are already curating THE COMPLETE #ESMO26 NEWSLETTER 📰 our picks of the top trials presented in Madrid, together in one email.
Register to receive it 👉 buff.ly/N5gYtAc
Every newsletter is curated by oncologists, for colleagues working in cancer aking science quick and accessible.
We are OncoAlert🚨 For Colleagues, by Colleagues
Best,
The Network
@cdanicas @hoperugo @DrChoueiri @TiansterZhang @matteolambe @NiuSanford @stolaney1 @christine_lovly @amerseburger @GlopesMd @tompowles1 @montypal @Icro_Meattini @PGrivasMDPhD @brian_rini @CathyEngMD @apolo_andrea @AndreaNecchi @DrSGraff @BenWestphalen @graokane @to_be_elizabeth @ElisaAgostinett @nataliagandur @UOzkerim @DrMirallas @DrYukselUrun @Lucarecco @mzugman @HHorinouchi @p_ciracimd @DraMartinezLago @DrVilmaPBarcia @GIMedOnc @MarioBalsaMD @scocmem @AmandaNizamMD @GaiaGriguolo @JankovicK @Dr_Oncologista @Erman_Akkus @WeOncologists @niklas_kluemper @Markuseckstein3
1
6
9
494
Claudio Luchini retweeted
PBPS companion meeting at The XXXVI International Congress of the International Academy of Pathology (IAP), photos courtesy of dear PBPS president, Dr.Huamin Wang. @Huaminwang6 @MichelleReidMD @navale_pooja @OlcaBasturk @Mvgs1706 @AgostiniVulajDO @VidyaArole @dianachenfd
2
9
24
898
Claudio Luchini retweeted
The new case of the quarter is live! The title is exciting: Beyond the Obvious: A Rare Epithelioid Neoplasm of the Pancreas! PBPS members, please check out the case and join the discussion. Log in to view and comment:
#pathtwitter #pathx #pbpath
pbpath.org/case-4-quarter…
#pathtwitter #pathx #pbpath
pbpath.org/case-4-quarter…
2
19
33
2,354
Claudio Luchini retweeted
#Pancreas cancer update: New pancreatic precursor lesion may be entering the canon: IPSN.
pubmed.ncbi.nlm.nih.gov/42128055/
@MichelleReidMD @OlcaBasturk @AgostiniVulajDO @Mvgs1706 @navale_pooja @dianachenfd @CLuchini10 @Huaminwang6 @RaulSGonzalezMD @MengxuePath @bekirMD @cui_min_GI_path
pubmed.ncbi.nlm.nih.gov/42128055/
@MichelleReidMD @OlcaBasturk @AgostiniVulajDO @Mvgs1706 @navale_pooja @dianachenfd @CLuchini10 @Huaminwang6 @RaulSGonzalezMD @MengxuePath @bekirMD @cui_min_GI_path
1
4
9
1,067
Claudio Luchini retweeted
A beautiful sunset retreat at the Squantum Club in Providence!
It was a memorable and fun evening with our outstanding faculty, residents, fellows, and colleagues at the annual Brown Pathology and Laboratory Medicine Faculty Research Retreat- celebrating innovative research, nd strengthening the collaborations that make our department such a vibrant academic community.
Special thanks to our Chair, Dr. Jake Kurtis, and Vice Chair, Dr. Geralyn Messerlian, for their extraordinary leadership, vision, and unwavering commitment to faculty development, mentorship, collaboration, and academic excellence.
Congratulations as well to all of our research pilot awardees and poster presenters for showcasing the exciting and impactful science taking place across Brown Pathology @BrownMedicine @BrownPathology
It was a memorable and fun evening with our outstanding faculty, residents, fellows, and colleagues at the annual Brown Pathology and Laboratory Medicine Faculty Research Retreat- celebrating innovative research, nd strengthening the collaborations that make our department such a vibrant academic community.
Special thanks to our Chair, Dr. Jake Kurtis, and Vice Chair, Dr. Geralyn Messerlian, for their extraordinary leadership, vision, and unwavering commitment to faculty development, mentorship, collaboration, and academic excellence.
Congratulations as well to all of our research pilot awardees and poster presenters for showcasing the exciting and impactful science taking place across Brown Pathology @BrownMedicine @BrownPathology
1
1
13
695
Claudio Luchini retweeted
È online su UnivrMagazine il mio editoriale dedicato all’mRNA 🧬
Un percorso nato dalla ricerca 🔬 e costruito grazie al confronto tra competenze diverse 🤝
Leggi l’articolo 👉 univrmagazine.it/2026/09/18/ist…
Un percorso nato dalla ricerca 🔬 e costruito grazie al confronto tra competenze diverse 🤝
Leggi l’articolo 👉 univrmagazine.it/2026/09/18/ist…
0
1
7
71
Claudio Luchini retweeted
🔬 Unlocking Pancreatobiliary Pathology
Join PBPS & USCAP for an interactive, case-based microscopy course covering challenging pancreatic and biliary lesions, from resections to small biopsies and cytology, dated Feb 3–5, 2027. Registration is open!
my.uscap.org/uscap/program/…
Join PBPS & USCAP for an interactive, case-based microscopy course covering challenging pancreatic and biliary lesions, from resections to small biopsies and cytology, dated Feb 3–5, 2027. Registration is open!
my.uscap.org/uscap/program/…
1
3
6
464
Claudio Luchini retweeted
It is the perfect time for #PBpath after the long weekend! The PBPS Journal Watch for June–August 2026 is out! Log in to download, read, and track new articles in pancreatobiliary pathology:
@MichelleReidMD @OlcaBasturk @CLuchini10 @navale_pooja
pbpath.org/current-journa…
@MichelleReidMD @OlcaBasturk @CLuchini10 @navale_pooja
pbpath.org/current-journa…
1
7
8
1,429
The novelties on PDAC based on the 2026 WHO Classification here presented and summarized rdcu.be/fBylk @SpringerPath
0
4
11
712
Claudio Luchini retweeted
Pancreatic Cancer Interception with KRAS Inhibitors youtu.be/PGwB7DrP8aE?si… via @YouTube
#pancreatic
#cancer
#pancreatic
#cancer
1
5
13
2,169
Claudio Luchini retweeted
🧬 PANCprAId | Resected PDAC
🤖 Histology-based AI predicts benefit from mFOLFIRINOX vs gemcitabine
📊 Validated in PRODIGE-24
✅ DFS interaction P=0.003
💡 Toward AI-guided adjuvant therapy.
🔗 doi.org/10.1200/JCO-26…
@OncoAlert
🤖 Histology-based AI predicts benefit from mFOLFIRINOX vs gemcitabine
📊 Validated in PRODIGE-24
✅ DFS interaction P=0.003
💡 Toward AI-guided adjuvant therapy.
🔗 doi.org/10.1200/JCO-26…
@OncoAlert
0
15
32
3,100
Claudio Luchini retweeted
New PBPS Case of the Quarter is now available. Members can now access & post comments. Please log in to view the post: pbpath.org/case-3-quarter…
@MichelleReidMD @OlcaBasturk @AgostiniVulajDO @Mvgs1706 @navale_pooja @dianachenfd @CLuchini10 @Huaminwang6 @RaulSGonzalezMD
@MichelleReidMD @OlcaBasturk @AgostiniVulajDO @Mvgs1706 @navale_pooja @dianachenfd @CLuchini10 @Huaminwang6 @RaulSGonzalezMD
1
4
7
438
Claudio Luchini retweeted
"Precision Pathology was launched to provide a dedicated platform for the rapid, disruptive advances in digital and computational pathology, multiplex tissue-based biomarker, liquid biopsy, and single-cell spatial multi-omics. Pathologist at the frontlines of precision health"
3
13
30
1,471
Claudio Luchini retweeted
✅Protocol #DIPLOMA2x2 RCT #Robot vs open #Whipple is out!! @e_mips @nine_degraaf @julia_menso @Abuhilal9Abu
➡️ 413 patients
➡️ 2:1 RPD:OPD
➡️ investigator-initiated, international, multicentre, patient- and assessor-blinded randomised non-inferiority trial
➡️ upfront tal cholangiocarcinoma without any vascular involvement.
➡️ roll-over of the DIPLOMA-2 trial
➡️ 20 high-volume centers
➡️ 7 European countries & USA
🔜 results…… #IHPBA2026
rdcu.be/fugtf
➡️ 413 patients
➡️ 2:1 RPD:OPD
➡️ investigator-initiated, international, multicentre, patient- and assessor-blinded randomised non-inferiority trial
➡️ upfront tal cholangiocarcinoma without any vascular involvement.
➡️ roll-over of the DIPLOMA-2 trial
➡️ 20 high-volume centers
➡️ 7 European countries & USA
🔜 results…… #IHPBA2026
rdcu.be/fugtf
2
18
44
4,701
Claudio Luchini retweeted
New online! Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus dlvr.it/TTYwm9
2
26
42
5,455